PL1881848T3 - Zapobieganie zakażeniu HIV za pomocą TMC278 - Google Patents

Zapobieganie zakażeniu HIV za pomocą TMC278

Info

Publication number
PL1881848T3
PL1881848T3 PL06725539T PL06725539T PL1881848T3 PL 1881848 T3 PL1881848 T3 PL 1881848T3 PL 06725539 T PL06725539 T PL 06725539T PL 06725539 T PL06725539 T PL 06725539T PL 1881848 T3 PL1881848 T3 PL 1881848T3
Authority
PL
Poland
Prior art keywords
tmc278
hiv
infection
prevention
Prior art date
Application number
PL06725539T
Other languages
English (en)
Inventor
Lieven Elvire Colette Baert
Paulus Joannes Lewi
Jan Heeres
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of PL1881848T3 publication Critical patent/PL1881848T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06725539T 2005-04-04 2006-04-04 Zapobieganie zakażeniu HIV za pomocą TMC278 PL1881848T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05102616 2005-04-04
EP06725539A EP1881848B1 (en) 2005-04-04 2006-04-04 Prevention of hiv-infection with tmc278
PCT/EP2006/061303 WO2006106103A2 (en) 2005-04-04 2006-04-04 Prevention of hiv- infection with tmc278

Publications (1)

Publication Number Publication Date
PL1881848T3 true PL1881848T3 (pl) 2013-06-28

Family

ID=34939113

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06725539T PL1881848T3 (pl) 2005-04-04 2006-04-04 Zapobieganie zakażeniu HIV za pomocą TMC278

Country Status (29)

Country Link
US (6) US20080194601A1 (pl)
EP (1) EP1881848B1 (pl)
JP (2) JP5632579B2 (pl)
KR (1) KR101360851B1 (pl)
CN (2) CN101155599A (pl)
AP (1) AP2617A (pl)
AR (1) AR053571A1 (pl)
AU (1) AU2006231585B2 (pl)
BR (1) BRPI0607649B8 (pl)
CA (1) CA2602231C (pl)
CY (1) CY1113950T1 (pl)
DK (1) DK1881848T3 (pl)
EA (1) EA011420B1 (pl)
ES (1) ES2402864T3 (pl)
HK (2) HK1117039A1 (pl)
HR (1) HRP20130296T1 (pl)
IL (1) IL184744A (pl)
ME (1) ME01517B (pl)
MX (1) MX2007012277A (pl)
MY (1) MY150091A (pl)
NZ (1) NZ556659A (pl)
PL (1) PL1881848T3 (pl)
PT (1) PT1881848E (pl)
RS (1) RS52724B (pl)
SI (1) SI1881848T1 (pl)
TW (2) TWI457136B (pl)
UA (1) UA90124C2 (pl)
WO (1) WO2006106103A2 (pl)
ZA (1) ZA200708454B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
ES2414982T7 (es) 2006-01-20 2021-11-05 Janssen Sciences Ireland Unlimited Co Tratamiento a largo plazo de infección por VIH con TCM278
WO2007147882A2 (en) * 2006-06-23 2007-12-27 Tibotec Pharmaceuticals Ltd. Aqueous suspensions of tmc278
AR065720A1 (es) 2007-03-14 2009-06-24 Tibotec Pharm Ltd Polvos para reconstitucion que comprenden rilpivirina dispersos en ciertos polimeros. uso. proceso.
RU2546529C2 (ru) * 2008-12-24 2015-04-10 Тиботек Фармасьютикалз Имплантируемые устройства для лечения вич
SG181759A1 (en) 2009-12-21 2012-07-30 Janssen R & D Ireland Degradable removable implant for the sustained release of an active compound
DE102011082871A1 (de) * 2011-09-16 2013-03-21 Florian, Prof. Dr. Lang Therapeutische und diagnostische Targets für Autoimmunität, inflammatorische Prozesse und/oder immuner Pathogenese und/oder von Erkrankungen, welche auf Autoimmunität, inflammatorische Prozessen und/oder immuner Pathogenese beruhen
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
MX2015007563A (es) 2012-12-14 2015-10-14 Glaxosmithkline Llc Composiciones farmaceuticas.
CA2961528A1 (en) 2014-09-26 2016-03-31 Glaxosmithkline Intellectual Property (No.2) Limited Long acting pharmaceutical compositions
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
HUP0302631A2 (hu) 2000-03-30 2003-11-28 Bristol-Myers Squibb Co. Stavudint tartalmazó elnyújtott hatóanyag-kibocsátású szemcsék
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
WO2004043433A2 (en) 2002-11-08 2004-05-27 Glaxo Group Limited Pharmaceutical antiviral compositions
US7204980B2 (en) 2002-11-18 2007-04-17 Phoenix Pharmacologics, Inc. Methods for inhibiting viral replication in vivo
BRPI0407329A (pt) 2003-02-07 2006-01-10 Janssen Pharmaceutica Nv Derivados de pirimidina para a prevenção de infecção de hiv
JP2006518373A (ja) 2003-02-21 2006-08-10 トリペップ アクチ ボラゲット Ｈｉｖ複製を抑制するためのグリシンアミド誘導体
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
ES2414982T7 (es) * 2006-01-20 2021-11-05 Janssen Sciences Ireland Unlimited Co Tratamiento a largo plazo de infección por VIH con TCM278
WO2007147882A2 (en) * 2006-06-23 2007-12-27 Tibotec Pharmaceuticals Ltd. Aqueous suspensions of tmc278

Also Published As

Publication number Publication date
EP1881848B1 (en) 2013-01-16
ZA200708454B (en) 2009-03-25
BRPI0607649B1 (pt) 2019-08-06
WO2006106103A2 (en) 2006-10-12
MY150091A (en) 2013-11-29
BRPI0607649B8 (pt) 2021-05-25
BRPI0607649A2 (pt) 2009-09-22
AU2006231585B2 (en) 2012-02-02
EP1881848A2 (en) 2008-01-30
US20200397783A1 (en) 2020-12-24
US20110077261A1 (en) 2011-03-31
US20220071997A1 (en) 2022-03-10
CY1113950T1 (el) 2016-07-27
AR053571A1 (es) 2007-05-09
CN101155599A (zh) 2008-04-02
HRP20130296T1 (hr) 2013-04-30
RS52724B (en) 2013-08-30
US20160296519A1 (en) 2016-10-13
JP2008534651A (ja) 2008-08-28
TWI457136B (zh) 2014-10-21
KR101360851B1 (ko) 2014-02-11
NZ556659A (en) 2012-03-30
CA2602231A1 (en) 2006-10-12
TW200709818A (en) 2007-03-16
TW201414495A (zh) 2014-04-16
JP5632579B2 (ja) 2014-11-26
CN103860560A (zh) 2014-06-18
JP2013079275A (ja) 2013-05-02
US10765674B2 (en) 2020-09-08
IL184744A (en) 2015-05-31
ME01517B (me) 2014-04-20
UA90124C2 (ru) 2010-04-12
AU2006231585A1 (en) 2006-10-12
US20160151276A1 (en) 2016-06-02
IL184744A0 (en) 2007-12-03
CA2602231C (en) 2014-03-25
EA011420B1 (ru) 2009-02-27
SI1881848T1 (sl) 2013-05-31
EA200702169A1 (ru) 2008-02-28
HK1117039A1 (en) 2009-01-09
AP2617A (en) 2013-03-18
MX2007012277A (es) 2007-10-17
AP2007004178A0 (en) 2007-10-31
PT1881848E (pt) 2013-04-15
DK1881848T3 (da) 2013-04-15
US20080194601A1 (en) 2008-08-14
ES2402864T3 (es) 2013-05-09
HK1198936A1 (en) 2015-06-19
WO2006106103A3 (en) 2007-06-07
KR20080009051A (ko) 2008-01-24

Similar Documents

Publication Publication Date Title
ZA200708454B (en) Prevention of HIV-infection with TMC278
AP2936A (en) Long term treatment of HIV-infection with TMC278
GB0512940D0 (en) Compounds and their use
GB0520743D0 (en) Compounds and their use
EP1912921A4 (en) COMPOUNDS ON TETRAAZAPORPHYRINBASE AND ITS USES
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1921066A4 (en) PYRIDYLPHENOL COMPOUND AND USE THEREOF
IL185223A0 (en) Compounds and uses thereof
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
GB0520737D0 (en) The preparation of olive oil
GB0804899D0 (en) Compound composition and use
GB0608797D0 (en) Novel agents and the use thereof
ZA200804378B (en) Iminopropene compound and use thereof
AU3686P (en) DOW30 Acmena smithii
GB0515688D0 (en) Compounds and their uses
GB0525328D0 (en) Compounds and their uses
GB0522867D0 (en) Compounds and their uses
GB0510067D0 (en) Compounds and their uses
GB0515913D0 (en) Compounds and their uses
GB0514471D0 (en) Compounds and their uses
GB0510263D0 (en) Compounds and their uses
GB0506545D0 (en) Compounds and their uses
GB0521176D0 (en) The easy light and fitting
ZA200705410B (en) Prodrugs of 2,4-pyrimidinediamine compounds and their uses
GB0521272D0 (en) Compounds and uses thereof